Jacob van Naarden, Chief Business Officer at Loxo Oncology, Inc. (LOXO), sold 3,100 shares at $137.09 ($426K) on 2018-12-11, disclosed to the SEC on 2018-12-12.
Open-market sale of $426k LOXO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.92 | 800 | $109K | 25.5% |
| 2 | $137.09 | 1,759 | $241K | 56.6% |
| 3 | $140.16 | 541 | $76K | 17.8% |
| Total | $137.32 avg | 3,100 | $426K | 100% |
| Filing → |
| LOXO | SELL | 2018-12-12 | $185K | — | Filing → |
| LOXO | SELL | 2018-12-12 | $120K | — | Filing → |
| LOXO | SELL | 2018-11-28 | $1.5M | — | Filing → |